Management Sciences for Health to Share Six Years of Pharmaceutical Systems Strengthening Experience in 46 Countries at Event in Arlington, VA
Arlington, VA—February 20, 2018—On Thursday, March 1, 2018, Management Sciences for Health (MSH) will host an end-of-program event for the USAID-funde...
High Levels of Dual-Class Drug Resistance in HIV-Infected Children Failing First-Line Antiretroviral Therapy in Southern Ethiopia
Clinical monitoring of pediatric HIV treatment remains a major challenge in settings where drug ...
Rates and Predictors of Attrition among Children on Antiretroviral Therapy in Ethiopia: A Prospective Cohort Study
Between December 2014 and September 2016, we conducted a prospective cohort study in eight health facilities in Ethiopia. Eligibility criteria include...
Building Blocks of Progress: Case Studies in Pharmaceutical Systems Strengthening
Timely Testing Improves Early Infant Diagnosis of HIV Infection
Since adopting Option B+ in 2011, Malawi has made significant progress in identifying and treating pregnant women living with HIV, thereby reducing ve...
Case Studies in Strengthening Pharma Systems: Evidence of Lasting Progress
New Collection of Case Studies Explores Most Promising Interventions to Strengthen Pharmaceutical Systems
Arlington, VA—February 6, 2018—A new compendium released today by the USAID-funded Systems for Improved Access to Pharmaceuticals and Services (SIAPS)...
Strengthening the Leadership and Management of Pharmaceutical Services in South Africa
SIAPS Philippines End of Project Report
Starting in 2012, the USAID-funded Systems for Improved Access to Pharmaceuticals and Services (SIAPS) Program built the capacity of TB stakeholders a...
![[Jahidul Hasan works on the adverse drug event report.]{Photo Credit: Liza Talukder}](https://msh.org/wp-content/uploads/2018/01/photo_2_jahidul_hasan_working_on_the_ade_report_photo_credit_liza_talukder.jpg)